Cuu Long Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Cuu Long Pharmaceutical has a total shareholder equity of ₫1,483.9B and total debt of ₫726.1B, which brings its debt-to-equity ratio to 48.9%. Its total assets and total liabilities are ₫2,396.5B and ₫912.7B respectively. Cuu Long Pharmaceutical's EBIT is ₫72.2B making its interest coverage ratio -8.9. It has cash and short-term investments of ₫226.9B.
Key information
48.9%
Debt to equity ratio
₫726.06b
Debt
| Interest coverage ratio | -8.9x |
| Cash | ₫226.89b |
| Equity | ₫1.48t |
| Total liabilities | ₫912.68b |
| Total assets | ₫2.40t |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DCL's short term assets (₫1,428.6B) exceed its short term liabilities (₫630.4B).
Long Term Liabilities: DCL's short term assets (₫1,428.6B) exceed its long term liabilities (₫282.3B).
Debt to Equity History and Analysis
Debt Level: DCL's net debt to equity ratio (33.6%) is considered satisfactory.
Reducing Debt: DCL's debt to equity ratio has reduced from 95.2% to 48.9% over the past 5 years.
Debt Coverage: DCL's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: DCL earns more interest than it pays, so coverage of interest payments is not a concern.